A jury ruled that Natera owes $44.9 million in damages to CareDx on grounds that Natera intentionally mislead the transplant community regarding its Prospera Kidney Transplant Technology by likening it to CareDx's AlloSure test; the jury also ruled that CareDx engaged in two accounts of false advertising.
Additive manufacturing, or 3D printing, has steadily become more mainstream in the medical device sector because of its ability to enable cost-effective, patient-centered device development, particularly in the fields of orthopedic, spine, maxillofacial, and pediatric surgery.
This webinar on April 6th will have perspectives from healthcare, the medical device sector, and the FDA to discuss how each are using 3D printing, the applications they are leveraging it for, how they can produce devices such as surgical tools more economically, the regulatory challenges they face, and how they can collaborate more effectively.
The key challenge for primary care is the current lack of means for population-wide screening as this significantly lowers our ability to catch the condition early in patients within this golden window.
To truly enhance the quality of care, healthcare organizations need more collaborative, less disruptive communication tools — mobile clinical technologies — that enable greater workflow efficiencies, faster response times, fewer errors, and higher levels of safety.
By Michael Schroeder Wednesday, March 16, 2022 5:00 PM
The company rolled out new programs, content, interactive tools and videos aimed at addressing family mental health. The offerings seek to fill in gaps in mental healthcare to ensure children and parents get the help they need.
A jury ruled that Natera owes $44.9 million in damages to CareDx on grounds that Natera intentionally mislead the transplant community regarding its Prospera Kidney Transplant Technology by likening it to CareDx's AlloSure test; the jury also ruled that CareDx engaged in two accounts of false advertising.
ABOUT Healthcare released their annual Patient Leakage and Keepage Report that surveyed 138 healthcare executives to assess the state of patients leaving for other healthcare systems, their reasons for doing so, and what is being done to stem the leakage.
By Frank Vinluan Wednesday, March 16, 2022 12:29 PM
Antibody drug conjugates have made scientific and regulatory progress in recent years. Sanofi is partnering with ADC specialist Seagen in a multi-drug alliance that keeps the pharmaceutical giant in the mix of this growing field of cancer therapies.
Cybersecurity company Censinet paired up with healthcare IT research company KLAS for the 2022 annual Best in KLAS report where they rank IT companies in healthcare in a variety of categories. Epic scored the highest in the most categories.
No comments